Share the post "Trident Texofab : Q1 2024 Financial Quarterly Report : YoY Sales Up 11.31 %, QoQ Down 14.78 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 11.31 % in the past year, decrease in net sales/revenue by -14.78 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 987.5 %. Marginal increase in other income during this quarter, up by 1640%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Trident Texofab Limited. Profit dropped by -639.53 % Year to Year, Trident Texofab Limited’s profitability dropped by -775.73 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -630.77 % Year to Year. EPS decreased by -790 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 23.1 Cr | Rs. 30.171 Cr | Rs. 25.712 Cr | -14.78 % | + 11.31 % |
| Expenses | Rs. 21.66 Cr | Rs. 29.15 Cr | Rs. 24.19 Cr | -17.02 % | + 11.68 % |
| Operating Profit | Rs. 1.44 Cr | Rs. 1.02 Cr | Rs. 1.52 Cr | + 49.02 % | + 5.56 % |
| OPM % | 6.23 % | 3.38 % | 5.91 % | + 2.53 % | -0.32 % |
| Other Income | Rs. 0.08 Cr | Rs. 0.05 Cr | Rs. 0.87 Cr | + 1640 % | + 987.5 % |
| Interest | Rs. 0.91 Cr | Rs. 1.14 Cr | Rs. 1.05 Cr | -7.89 % | + 15.38 % |
| Depreciation | Rs. 0.41 Cr | Rs. 0.42 Cr | Rs. 0.41 Cr | -2.38 % | + 0 % |
| Profit before tax | Rs. 0.2 Cr | Rs. -0.49 Cr | Rs. 0.93 Cr | + 289.8 % | + 365 % |
| Tax % | -23.35 % | -27.97 % | 24.46 % | + 52.43 % | + 47.81 % |
| Net Profit | Rs. -0.13 Cr | Rs. -0.1 Cr | Rs. 0.7 Cr | + 800 % | + 638.46 % |
| EPS in Rs | Rs. -0.13 | Rs. -0.1 | Rs. 0.69 | + 790 % | + 630.77 % |
Today, we’re looking at Trident Texofab Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 11.31 %. However, it did see a marginal slip of -14.78 % from the previous quarter. Expenses decreased slightly by -17.02 % quarter-on-quarter, aligning with the annual rise of 11.68 %. Operating profit, while up 5.56 % compared to last year, faced a quarter-on-quarter increase of 49.02 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.32 %, but an expansion of 2.53 % sequentially. Other income rose by 1640 % compared to the last quarter, despite an annual growth of 987.5 %. Interest expenses dropped significantly by -7.89 % from the previous quarter, yet the year-over-year increase remains at a moderate 15.38 %. Depreciation costs fell by -2.38 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax grew annually by 365 % but saw an increase from the preceding quarter by 289.8 %.
Tax expenses as a percentage of profits increased slightly by 47.81 % compared to last year, with a more notable quarter-on-quarter increase of 52.43 %. Net profit rose by 638.46 % year-on-year but experienced a 800 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 630.77 % but a quarterly rise of 790 %. In summary, Trident Texofab Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 23.1 Cr | Rs. 30.171 Cr | Rs. 25.712 Cr | -14.78 % | + 11.31 % |
| Expenses | Rs. 21.66 Cr | Rs. 29.15 Cr | Rs. 24.19 Cr | -17.02 % | + 11.68 % |
| Operating Profit | Rs. 1.44 Cr | Rs. 1.02 Cr | Rs. 1.52 Cr | + 49.02 % | + 5.56 % |
| Net Profit | Rs. -0.13 Cr | Rs. -0.1 Cr | Rs. 0.7 Cr | + 800 % | + 638.46 % |
| EPS in Rs | Rs. -0.13 | Rs. -0.1 | Rs. 0.69 | + 790 % | + 630.77 % |
In reviewing Trident Texofab Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 11.31 % year-on-year growth, although there was a slight dip of -14.78 % from the previous quarter. Expenses rose by 11.68 % compared to the previous year, with a decrease of -17.02 % quarter-on-quarter. Operating Profit surged by 5.56 % annually, and saw a 49.02 % increase from the last quarter.
Net Profit showed yearly increase of 638.46 %, and experienced a 800 % increase from the previous quarter. Earnings Per Share (EPS) rose by 630.77 % annually, however rose by 790 % compared to the last quarter. In essence, while Trident Texofab Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
